Literature DB >> 33717184

Influence of PTPN22 Allotypes on Innate and Adaptive Immune Function in Health and Disease.

Lucas H Armitage1, Mark A Wallet1,2, Clayton E Mathews1.   

Abstract

Protein tyrosine phosphatase, non-receptor type 22 (PTPN22) regulates a panoply of leukocyte signaling pathways. A single nucleotide polymorphism (SNP) in PTPN22, rs2476601, is associated with increased risk of Type 1 Diabetes (T1D) and other autoimmune diseases. Over the past decade PTPN22 has been studied intensely in T cell receptor (TCR) and B cell receptor (BCR) signaling. However, the effect of the minor allele on PTPN22 function in TCR signaling is controversial with some reports concluding it has enhanced function and blunts TCR signaling and others reporting it has reduced function and increases TCR signaling. More recently, the core function of PTPN22 as well as functional derangements imparted by the autoimmunity-associated variant allele of PTPN22 have been examined in monocytes, macrophages, dendritic cells, and neutrophils. In this review we will discuss the known functions of PTPN22 in human cells, and we will elaborate on how autoimmunity-associated variants influence these functions across the panoply of immune cells that express PTPN22. Further, we consider currently unresolved questions that require clarification on the role of PTPN22 in immune cell function.
Copyright © 2021 Armitage, Wallet and Mathews.

Entities:  

Keywords:  PTPN22; PTPN22 620Arg > Trp; autoimmunity; cell signaling; leukocytes; rs2476601; type 1 diabetes

Year:  2021        PMID: 33717184      PMCID: PMC7946861          DOI: 10.3389/fimmu.2021.636618

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  143 in total

1.  Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP.

Authors:  A Gjörloff-Wingren; M Saxena; S Williams; D Hammi; T Mustelin
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

2.  Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.

Authors:  Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Yingge Liu; Mogjiborahman Salek; Novella Rapini; Aaron D Schenone; Patrizia Saccucci; Lucia G Delogu; Federica Angelini; Maria Luisa Manca Bitti; Christian Schmedt; Andrew C Chan; Oreste Acuto; Nunzio Bottini
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

3.  Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.

Authors:  Adrian F Arechiga; Tania Habib; Yantao He; Xian Zhang; Zhong-Yin Zhang; Andrew Funk; Jane H Buckner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

4.  Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression.

Authors:  Benjamin J Schmiedel; Divya Singh; Ariel Madrigal; Alan G Valdovino-Gonzalez; Brandie M White; Jose Zapardiel-Gonzalo; Brendan Ha; Gokmen Altay; Jason A Greenbaum; Graham McVicker; Grégory Seumois; Anjana Rao; Mitchell Kronenberg; Bjoern Peters; Pandurangan Vijayanand
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

5.  The protein tyrosine phosphatase PTPN22 controls forkhead box protein 3 T regulatory cell induction but is dispensable for T helper type 1 cell polarization.

Authors:  G Fousteri; T Jofra; I Debernardis; S M Stanford; A Laurenzi; N Bottini; M Battaglia
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 6.  Protein tyrosine phosphatases in lymphocyte activation and autoimmunity.

Authors:  Inmoo Rhee; André Veillette
Journal:  Nat Immunol       Date:  2012-04-18       Impact factor: 25.606

7.  The common, autoimmunity-predisposing 620Arg > Trp variant of PTPN22 modulates macrophage function and morphology.

Authors:  Meihang Li; Hugues Beauchemin; Natalija Popovic; Alan Peterson; Eva d'Hennezel; Ciriaco A Piccirillo; Chao Sun; Constantin Polychronakos
Journal:  J Autoimmun       Date:  2017-02-22       Impact factor: 7.094

8.  PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.

Authors:  Yaya Wang; David Ewart; Juliet N Crabtree; Ami Yamamoto; Emily C Baechler; Parastoo Fazeli; Erik J Peterson
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

9.  Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.

Authors:  Vincent Plagnol; Joanna M M Howson; Deborah J Smyth; Neil Walker; Jason P Hafler; Chris Wallace; Helen Stevens; Laura Jackson; Matthew J Simmonds; Polly J Bingley; Stephen C Gough; John A Todd
Journal:  PLoS Genet       Date:  2011-08-04       Impact factor: 5.917

10.  Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes.

Authors:  Yan Ge; Suna Onengut-Gumuscu; Aaron R Quinlan; Aaron J Mackey; Jocyndra A Wright; Jane H Buckner; Tania Habib; Stephen S Rich; Patrick Concannon
Journal:  Diabetes       Date:  2015-12-02       Impact factor: 9.461

View more
  5 in total

Review 1.  Epigenetic regulation of B cells and its role in autoimmune pathogenesis.

Authors:  Fan Xiao; Ke Rui; Xiaofei Shi; Haijing Wu; Xiaoyan Cai; Kathy O Lui; Qianjin Lu; Esteban Ballestar; Jie Tian; Hejian Zou; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2022-10-12       Impact factor: 22.096

Review 2.  Functional Impact of Risk Gene Variants on the Autoimmune Responses in Type 1 Diabetes.

Authors:  Chelsea Gootjes; Jaap Jan Zwaginga; Bart O Roep; Tatjana Nikolic
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

Review 3.  Neglected Facts on Mycobacterium Avium Subspecies Paratuberculosis and Type 1 Diabetes.

Authors:  Veronika Ozana; Karel Hruska; Leonardo A Sechi
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

Review 4.  Genetic basis of defects in immune tolerance underlying the development of autoimmunity.

Authors:  Anne M Hocking; Jane H Buckner
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 5.  Ligament Alteration in Diabetes Mellitus.

Authors:  Olga Adamska; Artur Stolarczyk; Agata Gondek; Bartosz Maciąg; Jakub Świderek; Paweł Czuchaj; Krzysztof Modzelewski
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.